MDT
Medtronic plc. · Healthcare · Medical Devices
TECHSellZACKSHold
R500#306 today
$86.38
-0.07% today · -2.55% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- MDT −0.07% on the last session vs SPY +0.74%: −0.8 pts of stock-specific move.
- Aftermath, crossed below 200-day avg (Sep 29): After its 11 crosses below the 200-day average in the past 5 years, MDT typically lost 1.0% over the next week (median) and was higher only 36% of the time; half the outcomes fell between -2.9% and +0.3%. An ordinary week: +0.0%. Among S&P 500 stocks after crosses below the 200-day average, that ranks #460 of 497.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 17
In 44 days
estimated date
EPS estimate
$1.33
$1.32 to $1.34 · 23 analysts
Revenue estimate
$9.5B
$9.4B to $9.5B
Track record
8/8 beats
last 8 reports · moved ±3.8% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 BMO | 1Q2027 | $1.39 | $1.45 | +$0.06 (+4.5%) beat | — | +1.5% +2.2 vs SPY | +3.7% | +1.9% |
| Jun 3, 2026 BMO | 4Q2026 | $1.54 | $1.55 | +$0.01 (+0.6%) beat | $9.8B | +5.7% +6.4 vs SPY | +4.6% | +11.2% |
| Feb 17, 2026 BMO | 3Q2026 | $1.34 | $1.36 | +$0.02 (+1.9%) beat | $9.0B | -3.1% -3.3 vs SPY | -3.6% | -0.9% |
| Nov 18, 2025 BMO | 2Q2026 | $1.31 | $1.36 | +$0.05 (+3.5%) beat | $9.0B | +4.7% +5.5 vs SPY | +3.8% | +7.2% |
| Aug 19, 2025 BMO | $1.23 | $1.26 | +$0.03 (+2.4%) beat | — | -3.1% -2.6 vs SPY | -5.4% | -0.8% | |
| May 21, 2025 BMO | $1.58 | $1.62 | +$0.04 (+2.5%) beat | — | -2.3% -0.6 vs SPY | +0.2% | -5.9% | |
| Feb 18, 2025 BMO | $1.36 | $1.39 | +$0.03 (+2.2%) beat | — | -7.3% -7.5 vs SPY | -5.2% | -2.8% | |
| Nov 19, 2024 BMO | $1.25 | $1.26 | +$0.01 (+0.8%) beat | — | -3.0% -3.3 vs SPY | -1.8% | -2.1% | |
| Aug 20, 2024 BMO | $1.20 | $1.23 | +$0.03 (+2.5%) beat | — | +0.7% +0.8 vs SPY | -1.0% | +5.3% | |
| May 23, 2024 BMO | $1.45 | $1.46 | +$0.01 (+0.7%) beat | — | -5.1% -4.4 vs SPY | -2.5% | -6.0% | |
| Feb 20, 2024 BMO | $1.26 | $1.30 | +$0.04 (+3.2%) beat | — | +1.7% +2.2 vs SPY | +3.0% | -0.9% | |
| Nov 21, 2023 BMO | $1.18 | $1.25 | +$0.07 (+5.9%) beat | — | +4.6% +4.8 vs SPY | +3.2% | +4.6% | |
| Aug 22, 2023 BMO | $1.11 | $1.20 | +$0.09 (+8.1%) beat | — | +2.6% +2.9 vs SPY | +1.2% | -0.3% | |
| May 25, 2023 BMO | $1.55 | $1.57 | +$0.02 (+1.3%) beat | — | -4.5% -5.4 vs SPY | -2.5% | -5.4% | |
| Feb 21, 2023 BMO | $1.27 | $1.30 | +$0.03 (+2.4%) beat | — | +0.8% +2.8 vs SPY | -0.7% | -1.7% | |
| Nov 22, 2022 BMO | $1.28 | $1.30 | +$0.02 (+1.6%) beat | — | -5.3% -6.7 vs SPY | -5.2% | -7.1% | |
| Aug 23, 2022 BMO | $1.12 | $1.13 | +$0.01 (+0.9%) beat | — | -3.1% -2.8 vs SPY | 0.0% | -4.5% | |
| May 26, 2022 BMO | $1.56 | $1.52 | −$0.04 (−2.6%) miss | — | -5.8% -7.8 vs SPY | -6.4% | -6.7% | |
| Feb 22, 2022 BMO | $1.37 | $1.37 | $0.00 (0.0%) in line | — | +3.1% +4.2 vs SPY | -0.1% | +4.4% | |
| Nov 23, 2021 BMO | $1.29 | $1.32 | +$0.03 (+2.3%) beat | — | -3.0% -3.1 vs SPY | -3.6% | -8.7% | |
| Aug 24, 2021 BMO | $1.32 | $1.41 | +$0.09 (+6.8%) beat | — | — | — | — | |
| May 27, 2021 BMO | $1.42 | $1.50 | +$0.08 (+5.6%) beat | — | — | — | — | |
| Feb 23, 2021 BMO | $1.15 | $1.29 | +$0.14 (+12.2%) beat | — | — | — | — | |
| Nov 24, 2020 BMO | $0.80 | $1.02 | +$0.22 (+27.5%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Oct 31, 2026 | $1.33 (23) | $1.32 – $1.34 | -2% | -1.2% | ▲3 ▼13 | $9.5B | +6% |
| Next quarter · Jan 31, 2027 | $1.42 (23) | $1.38 – $1.48 | +5% | -0.5% | ▲3 ▼12 | $9.5B | +6% |
| Current year · Apr 30, 2027 | $5.97 (27) | $5.94 – $6.01 | +8% | +0.4% | ▲22 ▼2 | $39.1B | +8% |
| Next year · Apr 30, 2028 | $6.41 (28) | $6.24 – $6.63 | +7% | 0.0% | ▲11 ▼13 | $40.4B | +3% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.